510(k) Report

510(k) · Cleared

Cleared

POLARSTEM Cemented Femoral Stem

K203175510(k) TraditionalCleared Jul 22, 2021269-day reviewClass II21 CFR 888.3353

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Smith & Nephew, Inc. · LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented

Cleared on Jul 22, 2021 as substantially equivalent to K130728 (Smith & Nephew, Inc., 2013) after a 269-day review. Its family tree reaches back 6 generations to 1994.

Decided
Jul 22, 2021
Review
269 days
Class
Class II
Product code
LZO
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K932481 (1994). 8 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 6 generations backK932481 SL-Plus and SLR-PlusEncore Orthopedics, Inc. · 1994
  2. 5 generations backK001942 SL-Plus and SLR-Plus StemsPlus Orthopedics · 2000
  3. 4 generations backK021178 SL-Plus Lateralized StemPlus Orthopedics · 2002
  4. 3 generations backK072852 SL-Plus Standard and Lateral Hip StemsSmith & Nephew, Inc. · 2008
  5. 2 generations backK120211 SL-Plus Standard and Lateral Femoral Stem with TI/HA CoatingSmith & Nephew, Inc. · 2012
  6. 1 generation backK130728 Polarstem Standard and Lateral Femoral Stems with TI/HASmith & Nephew, Inc. · 2013 · Recalled
  7. This deviceK203175 POLARSTEM Cemented Femoral StemSmith & Nephew, Inc. · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K932481SL-Plus and SLR-PlusEncore Orthopedics, Inc.1994—
−5K001942SL-Plus and SLR-Plus StemsPlus Orthopedics2000—
−4K021178SL-Plus Lateralized StemPlus Orthopedics2002—
−3K072852SL-Plus Standard and Lateral Hip StemsSmith & Nephew, Inc.2008—
−2K120211SL-Plus Standard and Lateral Femoral Stem with TI/HA CoatingSmith & Nephew, Inc.2012—
−1K130728Polarstem Standard and Lateral Femoral Stems with TI/HASmith & Nephew, Inc.20131
0 (this device)K203175POLARSTEM Cemented Femoral StemSmith & Nephew, Inc.2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
200510
FIG. 1 — Lineage of K203175, 1994–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZO device

  1. #1 K192827 Quadra-Pscore 19.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K130728Polarstem Standard and Lateral Femoral Stems with TI/HA
Summary page 4
…Orthopaedics/87 Product Code: LZO Predicate Device: POLARSTEM Standard and Lateral Femoral Stems – K130728 The predicate devices have not been subject to a design related recal…
Smith & Nephew, Inc.20131

Also cleared against K130728: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 27 years and passes through 3 companies; a new generation was cleared every 6.1 years on median.
  • 2 of the 8 ancestors have a recall of any class.
  • 3 other devices also cite its predicate K130728.

How does its category compare?

All LZO devices

LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · LZO

14in 2025

2007: 92008: 112009: 72010: 152011: 132012: 142013: 262014: 132015: 122016: 102017: 162018: 182019: 282020: 182021: 122022: 112023: 102024: 112025: 142026 (partial year): 9
2007high 28 (2019) · low 7 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZO

119in 2025

2007: 87 days median2008: 63 days median2009: 83 days median2010: 78 days median2011: 87 days median2012: 98 days median2013: 100 days median2014: 85 days median2015: 115 days median2016: 177 days median2017: 257 days median2018: 163 days median2019: 109 days median2020: 112 days median2021: 170 days median2022: 279 days median2023: 122 days median2024: 111 days median2025: 119 days median2026 (partial year): 102 days median
2007high 279 (2022) · low 63 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZO

1in 2025

2007: 22008: 132009: 422011: 102012: 142014: 12015: 12016: 92017: 52018: 22019: 42020: 32022: 42023: 22024: 12025: 1
2007high 42 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZO

3,244in 2025

2007: 1382008: 1252009: 1892010: 3942011: 5442012: 9632013: 1,3702014: 1,4772015: 1,3482016: 1,7282017: 2,1652018: 3,1332019: 3,0662020: 1,9632021: 2,1992022: 1,9852023: 2,0662024: 2,5862025: 3,244
2007high 3,244 (2025) · low 125 (2008)2025

MAUDE reports naming product code LZO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079872138
2008116313125
200978342189
201015780394
2011138710544
2012149814963
20132610001,370
2014138511,477
20151211511,348
20161017791,728
20171625752,165
20181816323,133
20192810943,066
20201811231,963
20211217002,199
20221127941,985
20231012222,066
20241111112,586
20251411913,244
202691020—

What is it indicated for?

The POLARSTEM Cemented Femoral Stem is indicated for advanced degeneration of the hip joint as a result of degenerative, post-traumatic or rheumatoid arthritis; fracture or avascular necrosis of the femoral head; failure of previous hip surgery, such as joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or total hip replacement.

The POLARSTEM Cemented Femoral Stem is intended for single use only and is to be implanted with bone cement.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K203175: POLARSTEM Cemented Femoral Stem.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K203175

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026